• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Neurological

Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials

June 29, 2022 By Jim Hammerand

Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt Lake […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Implants, Neurological, News Well, Research & Development Tagged With: Blackrock Neurotech, FDA, University of Pittsburgh’s Rehab Neural Engineering Labs

SpineX enrolls first patient in spinal neuromodulation technology trial

June 28, 2022 By Sean Whooley

SpineX announced today that it enrolled the first patient in its pivotal trial evaluating the Scone neuromodulation device. Los Angeles-based SpineX will evaluate the safety and effectiveness of the non-invasive spinal neuromodulation technology for the treatment of neurogenic bladder. The first patient was enrolled at the Rancho Research Institute of the Rancho Los Amigos National […]

Filed Under: Clinical Trials, Implants, Neurological, Neuromodulation/Neurostimulation, Urology Tagged With: SpineX

FDA grants breakthrough nod for Carthera’s SonoCloud-9

June 22, 2022 By Sean Whooley

Carthera announced today that it received FDA breakthrough device designation for its SonoCloud-9 system. Paris-based Carthera designed SonoCloud-9 for implantation in a skull window below the skin. Once in place, the device becomes invisible. When activated for a few minutes using a transdermal needle connected to an external control unit, it uses low-intensity pulsed ultrasound […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Oncology, Regulatory/Compliance, Ultrasound Tagged With: CarThera, FDA

Data backs Pear Therapeutics digital therapeutic for opioid use disorder

June 14, 2022 By Sean Whooley

Pear Therapeutics (Nasdaq:PEAR) today shared real-world data highlighting low costs with its reSET-O prescription digital therapeutic (PDT). Boston-based Pear Therapeutics’ reSET-O represents the only FDA-authorized PDT for the treatment of opioid use disorder (OUD). Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Clinical Trials, Digital Health, Health Technology, Neurological, Patient Monitoring, Software / IT Tagged With: Pear Therapeutics

FDA clears Ekso Bionics’ robotic exoskeleton for use with MS patients

June 13, 2022 By Sean Whooley

Ekso Bionics (Nasdaq:EKSO) announced today that it received FDA 510(k) clearance for its EksoNR robotic exoskeleton. Richmond, California–based Ekso Bionics designed the EksoNR technology for use with Multiple Sclerosis (MS) patients. According to a news release, EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use in patients with MS, significantly expanding […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Health Technology, Neurological, News Well, Prosthetics, Regulatory/Compliance, Robotics Tagged With: Ekso Bionics

Pear Therapeutics reports positive real-world data for chronic insomnia treatment

June 8, 2022 By Sean Whooley

Pear Therapeutics (Nasdaq:PEAR) today announced real-world data from a trial of its Somryst prescription digital therapeutic (PDT). Data showed that Somryst, the only FDA-authorized PDT for treating chronic insomnia, achieved significant reductions in symptoms of insomnia, anxiety and depression severity both immediately following treatment and at six-months follow-up. Get the full story at our sister site, […]

Filed Under: Clinical Trials, Digital Health, Health Technology, Neurological, Software / IT Tagged With: Pear Therapeutics

Digital therapeutics developer Better Therapeutics names new CEO

June 7, 2022 By Sean Whooley

Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Frank Karbe as its new president and CEO. San Francisco-based Better Therapeutics develops prescription digital therapeutics (PDTs) based on nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Digital Health, Health Technology, Neurological, Software / IT Tagged With: Better Therapeutics, Personnel Moves

Medtronic announces new chief medical officer for neuromodulation unit

June 7, 2022 By Danielle Kirsh

Medtronic (NYSE:MDT) this week announced that it has appointed Dr. Ashwini Sharan as its neuromodulation operation unit chief medical officer. Sharan will be responsible for shaping the strategic direction of the Fridley, Minnesota-based company’s innovation and clinical evidence plans and help guide physician, society and education engagements. He will also serve as a medical advisor […]

Filed Under: Business/Financial News, Featured, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: Medtronic, Personnel Moves

InVivo Therapeutics completes enrollment in study of Nuero-Spinal Scaffold

June 2, 2022 By Sean Whooley

InVivo Therapeutics (Nasdaq:NVIV) announced today that it completed enrollment in the Inspire 2.0 study for patients with acute spinal cord injury. Cambridge, Massachusetts–based InVivo’s 20-patient randomized, controlled trial aims to enhance the clinical evidence for the company’s Neuro-Spinal Scaffold. The company designed the Neuro-Spinal Scaffold to encourage functional cells to fill a cavity that will […]

Filed Under: Clinical Trials, Implants, Neurological, Spine Tagged With: InVivo Therapeutics

Monteris Medical announces positive paper on its robotic brain surgery system

June 1, 2022 By Sean Whooley

Monteris Medical announced today that data supports the use of its laser interstitial thermal therapy (LITT) in treating brain tumors. A paper on LITT for patients with IDH wild-type glioblastoma — the most common and aggressive tumor originating in the brain — was published in the journal Neuro-Oncology Advances. Minnetonka, Minnesota-based Monteris said in a […]

Filed Under: Clinical Trials, Neurological, Oncology, Robotics, Surgical Tagged With: Monteris Medical

Axonics files FDA PMA supplement for 4th-gen rechargeable neurostimulator

May 31, 2022 By Sean Whooley

Axonics (Nasdaq:AXNX) announced that it filed a premarket approval (PMA) supplement with the FDA for its next-generation neurostimulator. Irvine, California–based Axonics designed its fourth-generation rechargeable sacral neuromodulation implantable neurostimulator (INS) to reduce the frequency with which a patient needs to recharge their implanted device to just once every six months for one hour. The current […]

Filed Under: Business/Financial News, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Axonics, Axonics Modulation Technologies

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 95
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS